FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Deblaere Johan
2. Issuer Name and Ticker or Trading Symbol

Accenture plc [ ACN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Operating Officer
(Last)          (First)          (Middle)

C/O ACCENTURE, 161 N. CLARK STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

10/22/2019
(Street)

CHICAGO, IL 60601
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A ordinary shares  10/22/2019    S(1)    333  D $182.8841 (2) 67336  D   
Class A ordinary shares  10/22/2019    S(1)    656  D $184.4169 (3) 66680  D   
Class A ordinary shares  10/22/2019    S(1)    872  D $185.086 (4) 65808  D   
Class A ordinary shares  10/22/2019    S(1)    491  D $186.5159 (5) 65317  D   
Class A ordinary shares  10/22/2019    S(1)    648  D $187.3583 (6) 64669  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan.
(2)  The transaction was executed in multiple trades at prices ranging from $182.69 to $183.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(3)  The transaction was executed in multiple trades at prices ranging from $183.82 to $184.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(4)  The transaction was executed in multiple trades at prices ranging from $184.87 to $185.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(5)  The transaction was executed in multiple trades at prices ranging from $186.02 to $187. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
(6)  The transaction was executed in multiple trades at prices ranging from $187.04 to $187.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Deblaere Johan
C/O ACCENTURE
161 N. CLARK STREET
CHICAGO, IL 60601


Chief Operating Officer

Signatures
/s/ Danika Haueisen, Attorney-in-Fact for Johan Deblaere 10/23/2019
**Signature of Reporting Person Date


Accenture (NYSE:ACN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Accenture Charts.
Accenture (NYSE:ACN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Accenture Charts.

Accenture Plc News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
Thursday 16 May 2024 (8 hours ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 14 May 2024 (2 days ago) • Edgar (US Regulatory)
Accenture Takes New Steps to Help Clients Scale Generative AI Responsibly
Tuesday 14 May 2024 (2 days ago) • Business Wire
Form 144 - Report of proposed sale of securities
Monday 13 May 2024 (3 days ago) • Edgar (US Regulatory)
Palo Alto Networks and Accenture Team to Secure the GenAI Transformation Journey
Monday 13 May 2024 (3 days ago) • PR Newswire (US)
Accenture Federal Services Wins $789 Million U.S. Navy SHARKCAGE Cybersecurity Contract
Thursday 9 May 2024 (1 week ago) • Business Wire
Virgin Media O2 Partners with Accenture to Enhance Private 5G Solutions for UK Businesses, Tapping into Estimated Half a Billion Pound UK Market
Wednesday 8 May 2024 (1 week ago) • Business Wire
Accenture and Mandiant Team to Help Organizations Strengthen Business Resilience Against Increasingly Sophisticated Cyber Threats
Tuesday 7 May 2024 (1 week ago) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 May 2024 (1 week ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 May 2024 (1 week ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 May 2024 (1 week ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 May 2024 (1 week ago) • Edgar (US Regulatory)